Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2
Sign Up to like & getrecommendations! Published in 2019 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfy132
Abstract: Abstract Background A reduction in renal angiomyolipoma volume observed with everolimus (EVE) treatment in patients with tuberous sclerosis complex (TSC) has been postulated to translate to clinical benefit by reducing the risk of renal hemorrhage… read more here.
Keywords: patients tuberous; tuberous sclerosis; exist exist; sclerosis complex ... See more keywords